This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

eCysticFibrosis Review

By eCysticFibrosis Review

Expert insight and analysis providing information directly relevant to cystic fibrosis care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

  1. 1.
    Antibiotics, Dosing, and CFTR09/30/2020
    17:46
  2. 2.
    Bringing Telemedicine to the CF Clinic: A Success Story09/02/2020
    24:24
  3. 3.
    CFTR, Growth & Liver Disease: A Clinical Perspective08/03/2020
    20:26
  4. 4.
    In the Clinic: Triple Combination CFTR Modulation06/02/2020
    25:18
  5. 5.
    Addressing Mental Health in CF05/05/2020
    20:45
  6. 6.
    Clinical Considerations: New Anti-Inflammatories & New CFTR Modulators10/11/2019
    21:28
  7. 7.
    Continuous Alternating Therapies: A Clinical Perspective08/10/2019
    21:27
  8. 8.
    In The Clinic: CFTR Modification & Nutritional Deficiencies06/21/2019
    17:59
  1. 9.
    Clinical Insight: CFTR Modulators03/08/2019
    28:02
  2. 10.
    Clinical Approaches to MDR Lung Infections01/18/2019
    22:51
  3. 11.
    Lung Transplant and CRC Screening10/26/2018
    25:05
  4. 12.
    CFTR Modulators: Clinical Insights02/03/2018
    31:01
  5. 13.
    Screening and Diagnosis of CFRD10/27/2017
    33:31
  6. 14.
    New Directions in CFTR Modification09/08/2017
    30:23
  7. 15.
    Nutritional Management for Individuals with CF: Practical Applications06/28/2017
    22:48
  8. 16.
    Adherence – What You Should be Telling Your Patients04/25/2017
    35:33
  9. 17.
    Weighing the Options in Managing Exacerbations02/28/2017
    26:46
  10. 18.
    Future Landscape of CFTR Modulators11/17/2016
    31:15
  11. 19.
    Pseudomonas aeruginosa Eradication and Outcomes: Key Questions09/15/2016
    24:29
  12. 20.
    Nutritional Issues in Cystic Fibrosis07/14/2016
    10:14
  13. 21.
    Trends in Inhaled Antibiotic Therapy05/17/2016
    28:51
  14. 22.
    Pulmonary Exacerbations and the Microbiology of the CF Lung03/30/2016
    22:07
  15. 23.
    The Current State of CFTR Modification01/28/2016
    22:49
  16. 24.
    Breaking Coverage of CAT trial12/22/2015
    6:08
  17. 25.
    Breaking Coverage of CAT trial12/22/2015
    5:40
  18. 26.
    Breaking Coverage of CAT trial12/22/2015
    5:14
  19. 27.
    Breaking Coverage of CAT trial12/22/2015
    11:54
  20. 28.
    Agents for the management of Pseudomonas aeruginosa infection11/19/2015
    33:38
  21. 29.
    Benefits of CFTR Modification Beyond FEV1 Improvement09/30/2015
    26:26
  22. 30.
    The Effects of CFTR-modifying Therapies08/20/2015
    32:06
  23. 31.
    Optimizing Nutrition in Individuals with Cystic Fibrosis06/23/2015
    23:53
  24. 32.
    Improving digestive capabilities in nutritionally compromised patients with CF04/16/2015
    27:35
  25. 33.
    P. aeruginosa eradication and reinfection02/26/2015
    26:56
  26. 34.
    Pulmonary exacerbations: diagnoses, and therapeutic regimens12/26/2014
    36:03
  27. 35.
    What Does CFTR Tell Us About Lung Disease?04/08/2014
    37:41
  28. 36.
    Behavioral Treatment to Improve Dietary Adherence and Weight Gain in Children with Cystic Fibrosis02/11/2014
    31:44
  29. 37.
    Highlights of the 27th Annual North American Cystic Fibrosis Conference01/08/2014
    14:30
  30. 38.
    Special Edition 2014 - Steven Rowe: Highlights of the 27th Annual North American Cystic Fibrosis Conference01/08/2014
    14:30
  31. 39.
    Highlights of the 27th Annual North American Cystic Fibrosis Conference01/08/2014
    14:52
  32. 40.
    Highlights of the 27th Annual North American Cystic Fibrosis Conference01/08/2014
    12:57
  33. 41.
    Highlights of the 27th Annual North American Cystic Fibrosis Conference01/08/2014
    15:44
  34. 42.
    New Therapies in Cystic Fibrosis Directed Toward the Basic Defect11/26/2013
    27:32
  35. 43.
    P. aeruginosa Eradication07/30/2013
    28:28
  36. 44.
    Strategies for the Improvement of Nutrition Outcomes05/29/2013
    24:27
  37. 45.
    Adherence to Chronic Inhaled Therapies03/28/2013
    30:45
  38. 46.
    Featured Cases: Emerging Pathogens in Cystic Fibrosis07/23/2012
    41:10
  39. 47.
    Featured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CF05/22/2012
    32:29
  40. 48.
    Featured Cases: Interventions to Improve Nutrition in Patients with CF03/20/2012
    36:50
  41. 49.
    Featured Cases: Modifiers of CF Lung Disease01/17/2012
    37:03
  42. 50.
    Featured Cases: Exacerbation Therapies11/18/2011
    29:19
  43. 51.
    Featured Cases: New Inhalation Therapies12/02/2010
    35:17
  44. 52.
    Featured Cases: State-of-the-Art Treatment for CF Lung Disease09/14/2010
    41:07
  45. 53.
    Featured Cases: Vitamin D and Bone Health07/13/2010
    26:49
  46. 54.
    Featured Cases: Nutritional Challenges and Complications in Patients with CF05/13/2010
    34:55
  47. 55.
    Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)03/09/2010
    33:46
  48. 56.
    Featured Cases: Cystic Fibrosis–Related Diabetes01/12/2010
    29:59
  49. 57.
    Measurement of Early Lung Disease in Children With Cystic Fibrosis01/15/2009
    26:07
  50. 58.
    Emerging Pathogens in Cystic Fibrosis11/13/2008
    32:50
  51. 59.
    How to Interpret Genetic Tests for Cystic Fibrosis09/18/2008
    39:59

Listen to eCysticFibrosis Review now.

Listen to eCysticFibrosis Review in full in the Spotify app